Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism

Clinical Endocrinology

Volumn 68, Issue 3, 2008, Pages 450-457

  Metso, Saara ^a,b   Auvinen, Anssi ^c,d   Salmi, Jorma ^a   Huhtala, Heini ^a,c   Jaatinen, Pia ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; FRACTURE; GASTROINTESTINAL DISEASE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORBIDITY; NEOPLASM; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VEIN DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FINLAND; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MORBIDITY; RISK FACTORS; YOUNG ADULT;

EID: 39149139659     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03064.x     Document Type: Article

References (33)

1. Franklyn, J.A. (1994) The management of hyperthyroidism. New England Journal of Medicine, 330, 1731 1738.
2. Goldman, M.B., Maloof, F., Monson, R.R., Aschengrau, A., Cooper, D.S. Ridgway, E.C. (1988) Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women. American Journal of Epidemiology, 127, 969 980.
3. Hall, P., Lundell, G. Holm, L.E. (1993) Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinologica, 128, 230 234.
4. Franklyn, J.A., Maisonneuve, P., Sheppard, M.C., Betteridge, J. Boyle, P. (1998) Mortality after the treatment of hyperthyroidism with radioactive iodine. New England Journal of Medicine, 338, 712 718.
5. Franklyn, J.A., Sheppard, M.C. Maisonneuve, P. (2005) Thyroid function and mortality in patients treated for hyperthyroidism. Journal of the American Medical Association, 294, 71 80.
6. Metso, S., Jaatinen, P., Huhtala, H., Auvinen, A., Oksala, H. Salmi, J. (2007) Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 92, 2190 2196.
7. Osman, F., Gammage, M.D. Franklyn, J.A. (2002) Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid, 12, 483 487.
8. Klein, I. Ojamaa, K. (2001) Thyroid hormone and the cardiovascular system. New England Journal of Medicine, 344, 501 509.
9. Flynn, R.W., Macdonald, T.M., Jung, R.T., Morris, A.D. Leese, G.P. (2006) Mortality and vascular outcomes in patients treated for thyroid dysfunction. Journal of Clinical Endocrinology and Metabolism, 91, 2159 2164.
10. Nyirenda, M.J., Clark, D.N., Finlayson, A.R., Read, J., Elders, A., Bain, M., Fox, K.A. Toft, A.D. (2005) Thyroid disease and increased cardiovascular risk. Thyroid, 15, 718 724.
11. Cappola, A.R. Ladenson, P.W. (2003) Hypothyroidism and atherosclerosis. Journal of Clinical Endocrinology and Metabolism, 88, 2438 2444.
12. Osman, F., Franklyn, J.A., Holder, R.L., Sheppard, M.C. Gammage, M.D. (2007) Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. Journal of the American College of Cardiology, 49, 71 81.
13. Heliövaara, M., Reunanen, A., Aromaa, A., Knekt, P., Aho, K. Suhonen, O. (1984) Validity of hospital discharge data in a prospective epidemiological study on stroke and myocardial infarction. Acta Medica Scandinavica, 216, 309 315.
14. Rapola, J.M., Virtamo, J., Korhonen, P., Haapakoski, J., Hartman, A.M., Edwards, B.K. Heinonen, O.P. (1997) Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland. European Journal of Epidemiology, 13, 133 138.
15. Leppälä, J.M., Virtamo, J. Heinonen, O.P. (1999) Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. European Journal of Epidemiology, 15, 155 160.
16. Pajunen, P., Koukkunen, H., Ketonen, M., Jerkkola, T., Immonen-Räihä, P., Karja-Koskenkari, P., Mähönen, M., Niemelä, M., Kuulasmaa, K., Palomäki, P., Mustonen, J., Lehtonen, A., Arstila, M., Vuorenmaa, T., Lehto, S., Miettinen, H., Torppa, J., Tuomilehto, J., Kesäniemi, Y.A., Pyörälä, K. Salomaa, V. (2005) The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. European Journal of Cardiovascular Prevention and Rehabilitation, 12, 132 137.
17. Metso, S., Jaatinen, P., Huhtala, H., Luukkaala, T., Oksala, H. Salmi, J. (2004) Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clinical Endocrinology, 61, 641 648.
18. Merce, J., Ferras, S., Oltra, C., Sanz, E., Vendrell, J., Simon, I., Camprubi, M., Bardaji, A. Ridao, C. (2005) Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. American Journal of Medicine, 118, 126 131.
19. Coban, E., Aydemir, M., Yazicioglu, G. Ozdogan, M. (2006) Endothelial dysfunction in subjects with subclinical hyperthyroidism. Journal of Endocrinological Investigation, 29, 197 200.
20. Erem, C., Ersoz, H.O., Karti, S.S., Ukinc, K., Hacihasanoglu, A., Deger, O. Telatar, M. (2002) Blood coagulation and fibrinolysis in patients with hyperthyroidism. Journal of Endocrinological Investigation, 25, 345 350.
21. Frost, L., Vestergaard, P. Mosekilde, L. (2004) Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Archives of Internal Medicine, 164, 1675 1678.
22. Petersen, P. Hansen, J.M. (1988) Stroke in thyrotoxicosis with atrial fibrillation. Stroke, 19, 15 18.
23. Collins, R., Armitage, J., Parish, S., Sleight, P. Peto, R. (2004) Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions. Lancet, 363, 757 767.
24. Turnbull, F. (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet, 362, 1527 1535.
25. Presti, C.F. Hart, R.G. (1989) Thyrotoxicosis, atrial fibrillation, and embolism, revisited. American Heart Journal, 117, 976 977.
26. Squizzato, A., Gerdes, V.E., Brandjes, D.P., Buller, H.R. Stam, J. (2005) Thyroid diseases and cerebrovascular disease. Stroke, 36, 2302 2310.
27. Nakazawa, H.K., Sakurai, K., Hamada, N., Momotani, N. Ito, K. (1982) Management of atrial fibrillation in the post-thyrotoxic state. American Journal of Medicine, 72, 903 906.
28. Hofbauer, L.C. Heufelder, A.E. (1997) Coagulation disorders in thyroid diseases. European Journal of Endocrinology, 136, 1 7.
29. Perros, P., McCrimmon, R.J., Shaw, G. Frier, B.M. (1995) Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabetic Medicine, 12, 622 627.
30. Metso, S., Auvinen, A., Huhtala, H., Salmi, J., Oksala, H. Jaatinen, P. (2007) Increased cancer incidence after radioiodine treatment for hyperthyroidism. Cancer, 109, 1972 1979.
31. Hoffman, D.A., McConahey, W.M., Diamond, E.L. Kurland, L.T. (1982) Mortality in women treated for hyperthyroidism. American Journal of Epidemiology, 115, 243 254.
32. Murphy, E. Williams, G.R. (2004) The thyroid and the skeleton. Clinical Endocrinology, 61, 285 298.
33. Cooper, D.S. (2005) Antithyroid drugs. New England Journal of Medicine, 352, 905 917.